Process for the preparation of (3R,3aS,6AR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarba mate

Details for Australian Patent Application No. 2004309122 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Zinser, Hartmut Burghard; Ebert, Birgit M.; Goyvaerts, Nicolaas Martha Felix; Wigerinck, Piet Tom Bert Paul

Agent Shelston IP

Pub. Number AU-B-2004309122

PCT Pub. Number WO2005/063770

Priority 03104949.7 23.12.03 EP; 60/568,183 04.05.04 US

Filing date 23 December 2004

Wipo publication date 14 July 2005

Acceptance publication date 21 July 2011

International Classifications

C07D 493/04 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

Event Publications

25 May 2006 PCT application entered the National Phase

  PCT publication WO2005/063770 Priority application(s): WO2005/063770

21 July 2011 Application Accepted

  Published as AU-B-2004309122

17 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004309146-Method for the identification of compounds modulating reverse transport of cholesterol

2004309118-Method of determining a fluid inflow profile of wellbore